MiMedx Group, Inc.
PosiFunda Ratios Only on PositoAI
PositoAI's own ratios from MiMedx Group, Inc.'s yearly results (2022–2025), compared with Healthcare companies in United States. Tap ? on any ratio for what it means.
What stands out
- Self-Funding Ratio: Over the last 3 years its own operating cash covered its investment spending (capex) 35.5 times. Higher than 98% of Healthcare companies in United States.
- Debt Due Cover Ratio: Debt due within a year is covered 49.3 times by its yearly operating cash. Higher than 95% of Healthcare companies in United States.
- Steadiness Ratio: Sales grew in 3 of the last 3 years; profit grew in 2 of 3. Steadier than 85% of Healthcare companies in United States.
Cash quality
Profit Cash Ratio
$112Over the last 3 years, every $100 of reported profit came with $112 of operating cash.
Lower than 76% of Healthcare companies in United States.
Self-Funding Ratio
35.5×Over the last 3 years its own operating cash covered its investment spending (capex) 35.5 times.
Higher than 98% of Healthcare companies in United States.
Cash Locked Ratio
$21For every $100 of sales, $21 is tied up in day-to-day operations (money owed by customers + stock − money owed to suppliers), against $18 tied up three years earlier.
Less money tied up than 56% of Healthcare companies in United States.
Growth quality
Steadiness Ratio
3/3 · 2/3Sales grew in 3 of the last 3 years; profit grew in 2 of 3.
Steadier than 85% of Healthcare companies in United States.
Growth Efficiency Ratio
$52Sales grew 56% in 3 years; of every extra $100 of sales, $52 became extra profit.
Higher than 70% of Healthcare companies in United States.
Asset Productivity Ratio
+56% / +100%In 3 years sales changed by +56% while total assets changed by +100%. Assets grew faster than sales.
Balance-sheet strength
Debt Due Cover Ratio
49.3×Debt due within a year is covered 49.3 times by its yearly operating cash.
Higher than 95% of Healthcare companies in United States.
Cash Cushion Ratio
+26%Cash, after subtracting all debt, equals 26% of its market value (net cash).
Higher than 67% of Healthcare companies in United States.
Tangible Assets Ratio
90%Of every $100 the company owns, $90 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles.
More tangible than 62% of Healthcare companies in United States.
Tangible Net Worth Ratio
87%Of every $100 of net worth, $87 is tangible; the rest is goodwill and other intangibles, often from buying other companies.
More tangible than 68% of Healthcare companies in United States.
Shareholders
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (13)
MiMedx Group, Inc. owes $0.23 for every $1 it owns. Net profit rose 15% in the year to Dec 2025.
Compared with Healthcare companies in United States · latest annual results Dec 2025.
P/E ratio
98.2Investors pay $98.2 for every $1 of MiMedx Group, Inc.'s yearly profit, higher than 90% of Healthcare companies in United States.
P/B ratio
2.66The share price is 2.66 times MiMedx Group, Inc.'s book value per share, higher than 51% of Healthcare companies in United States.
Market cap
$574 MThe total market value of all of MiMedx Group, Inc.'s shares at today's price (share price × number of shares), larger than 57% of Healthcare companies in United States. PosiCap size class: Mini Cap.
Net worth (book value)
$216 MWhat MiMedx Group, Inc. would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (30 Jun 2026).
Book value per share
$1.48Net worth divided by the number of shares. The share price of $3.93 is 2.7 times this, which is the P/B above.
Return on equity (ROE)
2.9%MiMedx Group, Inc. earned 2.9% on its shareholders' money over the last year, higher than 78% of Healthcare companies in United States.
Owes vs Owns
0.23×MiMedx Group, Inc. owes $0.23 for every $1 it owns (low), lower than 69% of Healthcare companies in United States.
Dividend yield
NoneMiMedx Group, Inc. does not currently pay a dividend.
Revenue growth
+20%Revenue rose 20% in the year to Dec 2025, and grew 16% a year on average over 3 years.
Profit growth
+15%Net profit rose 15% in the year to Dec 2025.
Profit margin
11.6%MiMedx Group, Inc. keeps $12 of every $100 of revenue as net profit.
Cash quality
1.5×Cash from MiMedx Group, Inc.'s business was 1.5× its reported profit in the year to Dec 2025 — its profit turned into cash.
Cash vs debt
Net cashMiMedx Group, Inc. held $148 M more cash than debt (net cash) at Dec 2025.
Questions
What is MiMedx Group, Inc.'s P/E ratio?
Investors pay $98.2 for every $1 of MiMedx Group, Inc.'s yearly profit, higher than 90% of Healthcare companies in United States.
How is P/B calculated on PositoAI?
P/B is market cap divided by net worth from the latest balance sheet. For MiMedx Group, Inc.: $574 M ÷ $216 M (30 Jun 2026) = 2.7.
What is MiMedx Group, Inc.'s return on equity?
MiMedx Group, Inc. earned 2.9% on its shareholders' money over the last year, higher than 78% of Healthcare companies in United States.
How much does MiMedx Group, Inc. owe compared with what it owns?
MiMedx Group, Inc. owes $0.23 for every $1 it owns (low), lower than 69% of Healthcare companies in United States.
Does MiMedx Group, Inc. pay a dividend?
No. MiMedx Group, Inc. does not currently pay a dividend.
Is MiMedx Group, Inc.'s revenue growing?
Revenue rose 20% in the year to Dec 2025, and grew 16% a year on average over 3 years.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.